Key result
Transvenous temporary cardiac pacing complications decline over time but remain high at ~23%.
Why the study?
Transvenous temporary cardiac pacing therapy is widely used to treat life-threatening arrhythmias, yet aggregated evidence on its use and outcomes is limited.
What are the indications, access routes, and complication rates associated with transvenous temporary cardiac pacing therapy?
Systematic Review (n=4,546)
What are the indications, access routes, and complication rates associated with transvenous temporary cardiac pacing therapy?
p-value: p=<0.001
Transvenous temporary pacing is associated with a high complication rate (36.7% historically, 22.9% recently), and the majority of patients subsequently require permanent pacemaker therapy.
No takes yet. Share an insight, caveat, or question.
High complication rates with transvenous temporary pacing warrant clinical caution; confirms need for safer techniques or alternatives.
Tjong et al. (2019) conducted a systematic review in Life-threatening arrhythmias requiring transvenous temporary cardiac pacing (n=4,546). Transvenous temporary cardiac pacing therapy (TV-TP) was evaluated on Complication incidence over time (10-year intervals) (p=<0.001). Transvenous temporary cardiac pacing therapy had an overall mean complication rate of 36.7%, which significantly decreased over time but remained high at 22.9% in the most recent period (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: